SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-16-009701
Filing Date
2016-05-05
Accepted
2016-05-04 18:15:08
Documents
96
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_050416p.htm 10-Q 570706
2 EXHIBIT 10.1 exh_101.htm EX-10.1 63581
3 EXHIBIT 10.2 exh_102.htm EX-10.2 186561
4 EXHIBIT 10.3 exh_103.htm EX-10.3 240577
5 EXHIBIT 10.4 exh_104.htm EX-10.4 52921
6 EXHIBIT 10.5 exh_105.htm EX-10.5 267838
7 EXHIBIT 31.1 exh_311.htm EX-31.1 9785
8 EXHIBIT 31.2 exh_312.htm EX-31.2 9768
9 EXHIBIT 32.1 exh_321.htm EX-32.1 3574
10 EXHIBIT 32.2 exh_322.htm EX-32.2 3555
17 GRAPHIC exh102_01.jpg GRAPHIC 157096
18 GRAPHIC exh102_02.jpg GRAPHIC 114222
  Complete submission text file 0001171843-16-009701.txt   5917365

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE scmp-20160331.xml EX-101.INS 698330
12 XBRL SCHEMA FILE scmp-20160331.xsd EX-101.SCH 67972
13 XBRL CALCULATION FILE scmp-20160331_cal.xml EX-101.CAL 51952
14 XBRL DEFINITION FILE scmp-20160331_def.xml EX-101.DEF 544458
15 XBRL LABEL FILE scmp-20160331_lab.xml EX-101.LAB 372148
16 XBRL PRESENTATION FILE scmp-20160331_pre.xml EX-101.PRE 563592
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33609 | Film No.: 161620945
SIC: 2834 Pharmaceutical Preparations